rethinkTHC Search
Menu
Study breakdown

Young psychosis patients who use cannabis have worse cognitive function than non-using patients

Meta AnalysisStrong evidence
The takeaway

A meta-analysis of 14 studies found that young psychosis patients who currently use cannabis performed worse on IQ, verbal learning, working memory, and motor inhibition tests, contradicting the idea that cannabis-using patients have better cognition.

Read this if you have psychosis and use cannabis and want to understand how it might affect your thinking and memory.

Cannabis-using psychosis patients performed worse on 5 cognitive domains but better on set-shifting

What the researchers found

Previous research had suggested that psychosis patients with lifetime cannabis use appeared to have better cognitive function than non-using patients. This meta-analysis challenged that finding by focusing specifically on current cannabis users and younger patients.

Across 14 studies, young psychosis patients who were currently using cannabis performed worse than non-using patients on several cognitive measures: premorbid IQ, current IQ, verbal learning, verbal working memory, and motor inhibition. This contradicts the narrative of cannabis-using psychosis patients having superior cognition.

One exception was conceptual set-shifting, where cannabis-using patients actually outperformed non-users. This isolated advantage amidst broader deficits suggests different cognitive profiles in cannabis-using versus non-using psychosis patients.

Age was a moderating factor, with older age predicting worse performance in processing speed, sustained attention, and verbal memory among cannabis users, but better performance in verbal learning and verbal fluency.

Why it matters

Understanding the cognitive effects of cannabis in psychosis is important for treatment planning and for understanding the biology of cannabis-associated psychosis. If cannabis-using patients have worse cognition, this challenges the idea that they represent a "healthier" subgroup and suggests cannabis may actively impair cognitive function on top of psychosis-related deficits.

The numbers in context

308 studies identified, 14 met inclusion criteria. Cannabis-using patients performed worse on: premorbid IQ, current IQ, verbal learning, verbal working memory, motor inhibition. Cannabis users outperformed non-users on conceptual set-shifting. Increasing age predicted worse cognitive performance in several domains among cannabis users.

How the study worked

Systematic search of 308 studies identified 14 comparing neurocognition between current cannabis users and non-users with psychotic disorders, with mean age between 15 and 45 years. Effect sizes were extracted from cognitive test performance and analyzed using random effects modeling with moderator analyses.

What this study cannot tell us

The studies used varied cognitive assessments, making direct comparison imperfect. The age range (15-45) is broad. Current cannabis use was defined differently across studies. The meta-analysis cannot determine whether cannabis caused the cognitive deficits or whether patients with worse cognition were more likely to continue using. Sample sizes within individual studies varied.

How to read the evidence

This is a meta-analysis synthesizing 14 studies, providing strong evidence for the cognitive effects of current cannabis use in young psychosis patients.

When this study was published

Published in 2018. Research on cannabis and cognition in psychosis continues to evolve.

The bigger picture

This meta-analysis helps resolve a confusing finding in the literature. The earlier observation that cannabis-using psychosis patients had better cognition likely reflected a comparison of lifetime users (many of whom had stopped) rather than current users. When the analysis focuses on those actively using cannabis, the cognitive picture is worse, suggesting cannabis compounds psychosis-related cognitive impairment.

Questions still open

  • Why do cannabis-using psychosis patients perform better on set-shifting but worse on most other cognitive tests? Does the cognitive impairment associated with cannabis use in psychosis reverse with cessation? Could the different cognitive profiles inform different treatment approaches?

Common questions

Does cannabis make psychosis patients think less clearly?
This meta-analysis found that psychosis patients who currently use cannabis scored worse on IQ tests, verbal learning, working memory, and motor inhibition compared to non-using patients. The effect was more pronounced with increasing age.
Is there anything cannabis users with psychosis are better at?
Interestingly, cannabis-using psychosis patients outperformed non-users on tests of conceptual set-shifting, which involves the ability to change thinking strategies. This isolated advantage amid broader deficits suggests a distinctive cognitive profile.

Read the original research

Meta-analysis of neurocognition in young psychosis patients with current cannabis use.

Journal of psychiatric research, 99, 22-32

Citation

Bogaty, Sophia E R; Lee, Rico S C; Hickie, Ian B; Hermens, Daniel F. (2018). Meta-analysis of neurocognition in young psychosis patients with current cannabis use.. Journal of psychiatric research, 99, 22-32. https://doi.org/10.1016/j.jpsychires.2018.01.010

Explore the wider topic